These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29041840)

  • 1. Identification of novel scaffolds to inhibit human mitotic kinesin Eg5 targeting the second allosteric binding site using in silico methods.
    Makala H; Ulaganathan V
    J Recept Signal Transduct Res; 2018 Feb; 38(1):12-19. PubMed ID: 29041840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of pyrazolo pyrimidine derivatives as inhibitors of mitotic kinesin Eg5 and anticancer agents.
    Muthuraja P; Veeramani V; Prakash S; Himesh M; Venkatasubramanian U; Manisankar P
    Bioorg Chem; 2019 Mar; 84():493-504. PubMed ID: 30594885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead Generation for Human Mitotic Kinesin Eg5 Using Structure-based Virtual Screening and Validation by In-vitro and Cell-based Assays.
    Makala H; Alexandar SP; Nagarajan D; Mahapatra SK; Ulaganathan V
    Curr Comput Aided Drug Des; 2021; 17(6):759-772. PubMed ID: 32703141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of new allosteric inhibition in Kinesin spindle protein Eg5.
    Yokoyama H; Sawada J; Katoh S; Matsuno K; Ogo N; Ishikawa Y; Hashimoto H; Fujii S; Asai A
    ACS Chem Biol; 2015 Apr; 10(4):1128-36. PubMed ID: 25622007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
    Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
    Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors.
    Talapatra SK; Tham CL; Guglielmi P; Cirilli R; Chandrasekaran B; Karpoormath R; Carradori S; Kozielski F
    Eur J Med Chem; 2018 Aug; 156():641-651. PubMed ID: 30031975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.
    Sun L; Sun X; Xie S; Yu H; Zhong D
    Biochem Biophys Res Commun; 2014 May; 447(3):465-70. PubMed ID: 24732354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-ligand interaction-based virtual screening for novel Eg5/kinesin spindle protein inhibitors.
    Nagarajan S; Skoufias DA; Kozielski F; Pae AN
    J Med Chem; 2012 Mar; 55(6):2561-73. PubMed ID: 22309208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying and characterising promising small molecule inhibitors of kinesin spindle protein using ligand-based virtual screening, molecular docking, molecular dynamics and MM‑GBSA calculations.
    Elseginy SA
    J Comput Aided Mol Des; 2024 Apr; 38(1):16. PubMed ID: 38556596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding patterns of inhibitors to different pockets of kinesin Eg5.
    Jia N; Zhang B; Huo Z; Qin J; Ji Q; Geng Y
    Arch Biochem Biophys; 2024 Jun; 756():109998. PubMed ID: 38641233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the intermediate states of ADP-ATP exchange: a simulation study on Eg5.
    Zhang W
    J Phys Chem B; 2011 Feb; 115(5):784-95. PubMed ID: 21192710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STLC-resistant cell lines as tools to classify chemically divergent Eg5 targeting agents according to their mode of action and target specificity.
    Indorato RL; DeBonis S; Kozielski F; Garcia-Saez I; Skoufias DA
    Biochem Pharmacol; 2013 Nov; 86(10):1441-51. PubMed ID: 24041742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents.
    Brier S; Lemaire D; DeBonis S; Forest E; Kozielski F
    J Mol Biol; 2006 Jul; 360(2):360-76. PubMed ID: 16780877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance.
    Garcia-Saez I; Skoufias DA
    Biochem Pharmacol; 2021 Feb; 184():114364. PubMed ID: 33310050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into a unique inhibitor binding pocket in kinesin spindle protein.
    Ulaganathan V; Talapatra SK; Rath O; Pannifer A; Hackney DD; Kozielski F
    J Am Chem Soc; 2013 Feb; 135(6):2263-72. PubMed ID: 23305346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An allosteric transition trapped in an intermediate state of a new kinesin-inhibitor complex.
    Kaan HY; Ulaganathan V; Hackney DD; Kozielski F
    Biochem J; 2009 Dec; 425(1):55-60. PubMed ID: 19793049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational fragment-based drug design to explore the hydrophobic sub-pocket of the mitotic kinesin Eg5 allosteric binding site.
    Oguievetskaia K; Martin-Chanas L; Vorotyntsev A; Doppelt-Azeroual O; Brotel X; Adcock SA; de Brevern AG; Delfaud F; Moriaud F
    J Comput Aided Mol Des; 2009 Aug; 23(8):571-82. PubMed ID: 19533373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Machine Learning and Chemoinformatics-Based Screening of Mycotic Compounds against Kinesin Spindle ProteinEg5 for Lung Cancer Therapy.
    Maiti P; Sharma P; Nand M; Bhatt ID; Ramakrishnan MA; Mathpal S; Joshi T; Pant R; Mahmud S; Simal-Gandara J; Alshehri S; Ghoneim MM; Alruwaily M; Awadh AAA; Alshahrani MM; Chandra S
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5.
    Debonis S; Skoufias DA; Indorato RL; Liger F; Marquet B; Laggner C; Joseph B; Kozielski F
    J Med Chem; 2008 Mar; 51(5):1115-25. PubMed ID: 18266314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.